← Leaderboards
Michael Schlame
New York University School Of Medicine
$5,137,877
Attributed
$5,907,592
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $872.5K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,907,592 · 3
By mechanism
R01$5,907,592 · 3
Top collaborators
- M Mahmood Hussain3 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- M Mahmood Hussain$20,347,941
- Mindong Ren$1,348,071
- Ira Jay Goldberg$42,989,404
- Thomas A Neubert$9,047,558
Others in their field
Top investigators on “Phospholipids”
- Eugene W. St Clair · Duke University$24,182,181
- Valerian E Kagan · Wistar Institute$23,533,341
- Stanley J Opella · Wistar Institute$22,975,332
- Joel S. Bennett · University Of Pennsylvania$17,733,101
- George M. Carman · Rutgers The St Univ Of Nj New Brunswick$16,801,187
- Daniel E Kahne · Harvard University$16,303,151
Research focus
PhospholipidsLipidsAffectFatty AcidsLinkMitochondriaCardiolipinsMitochondrial MembraneMolecularMutation3-Methylglutaconic Aciduria Type 2InsightMembraneFunctional DisorderOrganellesEnzymesCardiomyopathiesAcyltransferasePublic HealthSpecificityLaboratoriesDrosophila GenusOxidative PhosphorylationPathologic
Grant awards (17)
The Function of Mammalian LPGAT1$516,587
R01 · FY2025 · HL · contact PI
The Function of Mammalian LPGAT1$506,256
R01 · FY2024 · HL · contact PI
The Function of Mammalian LPGAT1$516,587
R01 · FY2023 · HL · contact PI
Aberrant Cardiolipin Dynamics in Barth Syndrome - Renewal - 1$355,950
R01 · FY2023 · GM · contact PI
Aberrant Cardiolipin Dynamics in Barth Syndrome - Renewal - 1$355,950
R01 · FY2022 · GM · contact PI
Aberrant Cardiolipin Dynamics in Barth Syndrome - Renewal - 1$355,950
R01 · FY2021 · GM · contact PI
Aberrant Cardiolipin Dynamics in Barth Syndrome$5,544
R01 · FY2021 · GM · contact PI
Aberrant Cardiolipin Dynamics in Barth Syndrome - Renewal - 1$355,950
R01 · FY2020 · GM · contact PI
Abberant cardiolipin dynamics in Barth Syndrome$351,233
R01 · FY2018 · GM · contact PI
Abberant cardiolipin dynamics in Barth Syndrome$351,233
R01 · FY2017 · GM · contact PI
Abberant cardiolipin dynamics in Barth Syndrome$377,335
R01 · FY2016 · GM · contact PI
Abberant cardiolipin dynamics in Barth Syndrome$406,800
R01 · FY2015 · GM · contact PI
Molecular Mechanism of Barth Syndrome$328,198
R01 · FY2009 · HL · contact PI
Molecular Mechanism of Barth Syndrome$129,623
R01 · FY2009 · HL · contact PI
Molecular Mechanism of Barth Syndrome$328,198
R01 · FY2008 · HL · contact PI
Molecular Mechanism of Barth Syndrome$328,198
R01 · FY2007 · HL · contact PI
Molecular Mechanism of Barth Syndrome$338,000
R01 · FY2006 · HL · contact PI